raloxifene hydrochloride has been researched along with dihydrotestosterone in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (40.00) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, LW; Neubauer, BL; Petrow, V; Sikes, RA; Thomsen, S | 1 |
de Launoit, Y; Dufour, M; Labrie, F; Simard, J; Veilleux, R | 1 |
Dauvois, S; Dumont, M; Hatton, AC; Labrie, C; Labrie, F; Mérand, Y; Poirier, D; Poulin, R; Simard, J; Zhao, HF | 1 |
Couët, J; Dauvois, S; Dumont, M; Hatton, AC; Labrie, C; Labrie, F; Petitclerc, L; Poulin, R; Simard, J; Zhao, HF | 1 |
Biser, P; Goode, RL; Hoover, DM; Jones, CD; Mariotti, A; Neubauer, BL; Thornton, MO; Thornton, T | 1 |
Dufour, JM; Labrie, F; Levesque, C; Merand, Y; Poirier, D; Poulin, R | 1 |
Dauvois, S; Haagensen, DE; Hatton, AC; Labrie, C; Labrie, F; Simard, J; Zhao, HF | 1 |
Baker, D; Labrie, F; Poulin, R | 1 |
Bégin, D; Labrie, F; Luthy, IA | 1 |
Furlanetto, RW; Rodgers, RJ; Veldhuis, JD | 1 |
Amir-Zaltsman, Y; Jaffe, A; Knoll, E; Kohen, F; Somjen, D; Stern, N | 1 |
Hendel, D; Katzburg, S; Kaye, AM; Posner, GH; Somjen, D; Waisman, A | 1 |
Bleiberg, I; Kaye, AM; Ofer, M; Somjen, D | 1 |
Somjen, D | 1 |
Abbondanza, C; Bellastella, A; Bellastella, G; Chieffi, P; De Bellis, A; De Rosa, C; Della Ragione, F; Maione, L; Prezioso, D; Rossi, V; Sinisi, AA; Visconti, D | 1 |
1 review(s) available for raloxifene hydrochloride and dihydrotestosterone
Article | Year |
---|---|
Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.
Topics: Animals; Bone and Bones; Calcitriol; Creatine Kinase; Dihydrotestosterone; Drug Interactions; Estradiol; Estrogens; Female; Humans; In Vitro Techniques; Male; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Vitamin D | 2007 |
14 other study(ies) available for raloxifene hydrochloride and dihydrotestosterone
Article | Year |
---|---|
Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; DNA; Drug Therapy, Combination; Estrogen Antagonists; Female; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Piperidines; Progesterone; Prostatic Hyperplasia; Raloxifene Hydrochloride; Urogenital System | 1990 |
Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
Topics: Androgens; Androstane-3,17-diol; Binding, Competitive; Cell Cycle; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Antagonism; Estradiol; Estrogen Antagonists; Estrone; Flow Cytometry; Flutamide; Humans; In Vitro Techniques; Male; Metribolone; Piperidines; Prostatic Neoplasms; Raloxifene Hydrochloride; Tamoxifen; Testosterone; Time Factors; Tumor Cells, Cultured | 1991 |
Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Topics: Androgens; Androstenediol; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carrier Proteins; Cell Division; Dihydrotestosterone; Estrogens; Gene Expression; Glucocorticoids; Glycoproteins; Humans; In Vitro Techniques; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cells.
Topics: Apolipoproteins; Apolipoproteins D; Biomarkers, Tumor; Breast Neoplasms; Carrier Proteins; Cell Division; Dexamethasone; Dihydrotestosterone; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Glycoproteins; Humans; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Raloxifene Hydrochloride; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1990 |
Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758).
Topics: Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Epithelium; Estradiol; Estrogen Antagonists; Guinea Pigs; Male; Muscles; Orchiectomy; Organ Size; Piperidines; Raloxifene Hydrochloride; Receptors, Androgen; Receptors, Estrogen; Seminal Vesicles | 1989 |
Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
Topics: Binding, Competitive; Breast Neoplasms; Cell Division; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Humans; Piperidines; Polyunsaturated Alkamides; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1989 |
Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
Topics: Apolipoproteins; Apolipoproteins D; Blotting, Northern; Breast Neoplasms; Carrier Proteins; Cell Division; Dexamethasone; Dihydrotestosterone; DNA Probes; Estradiol; Estrogen Antagonists; Estrogens; Female; Gene Expression Regulation; Glycoproteins; Humans; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Raloxifene Hydrochloride; RNA, Messenger | 1989 |
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Topics: Androgen Antagonists; Androstenedione; Breast Neoplasms; Cell Division; Cell Line; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Flutamide; Humans; Piperidines; Raloxifene Hydrochloride; Receptors, Androgen; Receptors, Estrogen; Testosterone | 1988 |
Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
Topics: Androgen Antagonists; Animals; Cell Division; Cell Line; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Kinetics; Male; Mammary Neoplasms, Experimental; Mice; Piperidines; Raloxifene Hydrochloride; Receptors, Androgen; Testosterone | 1988 |
Synergistic actions of estradiol and the insulin-like growth factor somatomedin-C on swine ovarian (granulosa) cells.
Topics: Animals; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Female; Granulosa Cells; Hydroxycholesterols; Insulin-Like Growth Factor I; Kinetics; Piperidines; Pregnenolone; Progesterone; Raloxifene Hydrochloride; Somatomedins; Swine | 1986 |
Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells.
Topics: Analysis of Variance; Androgen Antagonists; Antibodies, Monoclonal; Cell Division; Cell Line; Cells, Cultured; Creatine Kinase; Dihydrotestosterone; DNA; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Flutamide; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Piperidines; Platelet-Derived Growth Factor; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Thymidine | 1998 |
Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts.
Topics: Calcitriol; Creatine Kinase; Dihydrotestosterone; Estradiol; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2004 |
The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences.
Topics: Aging; Alkaline Phosphatase; Animals; Bone Marrow Cells; Calcitriol; Cell Differentiation; Cells, Cultured; Creatine Kinase; Dexamethasone; Dihydrotestosterone; Estradiol; Female; Male; Orchiectomy; Osteoblasts; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred WKY; Sex Characteristics | 2005 |
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Humans; Male; Metallothionein; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Raloxifene Hydrochloride; Receptors, Thrombin; RNA, Messenger; Selective Estrogen Receptor Modulators; Signal Transduction; Time Factors; Transcription, Genetic | 2011 |